The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients

Atherosclerosis

Volumn 201, Issue 1, 2008, Pages 117-123

  Barbieri, Michelangela ^a   Marfella, Raffaele ^a   Rizzo, Maria Rosaria ^a   Boccardi, Virginia ^a   Siniscalchi, Mario ^b   Schiattarella, Concetta ^a   Siciliano, Silvio ^c   Lemme, Pietro ^b   Paolisso, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b F Veneziale Hospital   (Italy)

^c MONALDI HOSPITAL   (Italy)

Author keywords

Caucasians; Myocardial infarction risk; PSAM6 gene; Type 2 diabetes

Indexed keywords

PROTEASOME; PROTEASOME SUBUNIT ALPHA TYPE 6 PROTEIN; PROTEIN SUBUNIT; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSMA6 GENE; QUANTITATIVE ANALYSIS; UNTRANSLATED REGION; UPREGULATION;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 53849091015     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.01.005     Document Type: Article

References (27)

1. Herrmann J., Ciechanover A., Lerman L.O., and Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis exetended. Cardiovasc Res 61 (2004) 11-21
2. Powell S.R. The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 214 (2006) 989-997
3. Patterson C., Ike C., Willis P.W., Stouffer G.A., and Willis M.S. The bitter end: the ubiquitin-proteasome System and Cardiac Dysfunction. Circulation 115 (2007) 1456-1463
4. Willis Monte S., and Patterson C. Into the heart: the emerging role of ubiquitin-proteasome system. J Molec Cell Card 41 (2006) 567-579
5. Herrmann J., Gulati R., Napoli C., et al. Oxidative stress-related increase in ubiquitination in early coronary atherosclerosis. FASEB J 17 (2003) 1730-1732
6. Palombella V.J., Rando J., Goldberg A., and Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78 (1994) 773-785
7. Collins T., and Cybulsky M.I. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest 107 (2001) 255-264
8. Kannel W.B., and McGee D.L. Diabetes and cardiovascular diseases. The Framingham Study. JAMA 241 (1979) 2035-2038
9. Hu F.B., Stampfer M.J., Haffner S.M., et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diab Care 25 (2002) 1129-1134
10. Lecker S.H., Solomon V., Price S.R., et al. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 104 (1999) 1411-1420
11. Marfella R., Cacciapuoti F., Grassia A., et al. Role of the ubiquitin-proteasome system in carotid plaque instability in diabetic patients. Acta Cardiol 61 6 (2006) 630-636
12. Marfella R., D'Amico M., Esposito K., et al. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Diabetes 55 (2006) 622-632
13. Marfella R., D'Amico M., Cacciapuoti F., et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. J Am Coll Cardiol 47 (2006) 2444-2455
14. Ozaki K., Sato H., Iida A., et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanase population. Nat Genet 38 (2006) 921-925
15. Sjakste T., Poudziunas I., Ninio E., et al. SNPs of PSMA6 gene investigation of possible association with myocardial infarction and type 2 diabetes mellitus. Genetika 43 4 (2007) 553-559
16. Takashima N., Shioji K., Kokubo Y., et al. Validation of the association between the gene enconding proteasome subunit a type 6 and myocardial infarction in a Japanase population. Circ J 71 (2007) 495-498
17. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diab Med 1998;15:539-53.
18. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifugation. Clin Chem 18 (1972) 499-502
19. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003) 895-899
20. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65 (1996) 801-847
21. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 9 (1997) 788-799
22. Ciechanover A., Orian A., and Schwartz A.L. The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications. J Cell Biochem Suppl 34 (2000) 40-51
23. Amir R., Ciechanover A., and Cohen S. The ubiquitin-proteasome system: The relationship between protein degradation and human diseases. Harefuah 140 (2001) 1172-1176
24. Kikuchi J., Furukawa Y., and Kubo N. Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) 128-134
25. Ishii T., Itoh K., Sato H., and Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radic Res 31 (1999) 351-355
26. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
27. Baeurle P.A. IKB-NFKB structures: at the interface of inflammation control. Cell 95 (1998) 729-731